NeoGenomics Inc (NEO)
Quick ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 367,012 | 361,992 | 355,085 | 331,914 | 342,488 | 306,239 | 289,074 | 275,609 | 263,180 | 266,126 | 283,637 | 305,896 | 316,827 | 340,565 | 368,796 | 611,970 | 228,713 | 233,233 | 295,281 | 86,254 |
| Short-term investments | US$ in thousands | 19,832 | 25,821 | 32,770 | 52,916 | 72,715 | 96,025 | 120,272 | 142,306 | 174,809 | 177,414 | 182,316 | 175,534 | 198,563 | 202,144 | 202,950 | 190,710 | 67,546 | 50,375 | — | — |
| Receivables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 301,241 | 296,406 | 289,959 | 76,710 | 96,304 | 92,926 | 94,848 | 86,606 | 89,932 | 85,003 | 82,670 | 82,070 | 87,232 | 92,737 | 99,131 | 67,750 | 73,183 | 64,612 | 61,700 | 67,649 |
| Quick ratio | 1.28 | 1.31 | 1.34 | 5.02 | 4.31 | 4.33 | 4.32 | 4.83 | 4.87 | 5.22 | 5.64 | 5.87 | 5.91 | 5.85 | 5.77 | 11.85 | 4.05 | 4.39 | 4.79 | 1.28 |
December 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($367,012K
+ $19,832K
+ $—K)
÷ $301,241K
= 1.28
The quick ratio of NeoGenomics Inc has exhibited fluctuations over the period from March 31, 2020, to December 31, 2024. The quick ratio, which measures the company's ability to meet its short-term obligations with its most liquid assets, experienced a notable increase from 1.28 on March 31, 2020, to 11.85 on March 31, 2021. This significant surge indicates a substantial improvement in the company's liquidity position and its ability to cover its current liabilities with its quick assets.
However, the quick ratio gradually decreased in the subsequent quarters but still remained relatively high, indicating a healthy liquidity position for the company. As of December 31, 2024, the quick ratio stood at 1.28, which is a return to a level similar to that of March 31, 2020. This decrease may suggest a potential decrease in the company's ability to meet its short-term obligations with its quick assets.
Overall, the general trend in NeoGenomics Inc's quick ratio indicates fluctuations but consistently above 1, implying that the company has an adequate level of quick assets to cover its current liabilities. However, stakeholders should continue to monitor any further shifts in the quick ratio to assess the company's liquidity position and ability to meet its short-term financial obligations effectively.